Response assessment using (68)Ga-PSMA ligand PET in patients undergoing (177)Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer

PURPOSE: The first aim of this study was to evaluate (68)Ga-PSMA(HBED-CC) conjugate 11 positron emission tomography (PSMA PET) parameters for assessment of response to (177)Lu-PSMA-617 radioligand therapy (RLT) in patients with metastatic castration-resistant prostate cancer (mCRPC). The second aim...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Eur J Nucl Med Mol Imaging
Autori principali: Grubmüller, Bernhard, Senn, Daniela, Kramer, Gero, Baltzer, Pascal, D’Andrea, David, Grubmüller, Karl Hermann, Mitterhauser, Markus, Eidherr, Harald, Haug, Alexander R., Wadsak, Wolfgang, Pfaff, Sarah, Shariat, Shahrokh F., Hacker, Marcus, Hartenbach, Markus
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer Berlin Heidelberg 2018
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6451716/
https://ncbi.nlm.nih.gov/pubmed/30569186
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-018-4236-4
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi